Hyperbaric Oxygen Therapy in Saskatchewan

Yes, the Saskatchewan Health Authority covers hyperbaric oxygen therapy for the 14 Health Canada-recognised conditions when the in-province chamber at Dr. F.H. Wigmore Regional Hospital in Moose Jaw is available. Wigmore has operated on reduced hours since the July 2021 COVID-related closure and partial reopening; when in-province capacity is unavailable, the Saskatchewan Ministry of Health may approve interprovincial referrals to Foothills Medical Centre in Calgary, AB (approximately 675 km from Moose Jaw) or Misericordia Community Hospital in Edmonton. Travel and accommodation are typically the patient's responsibility unless covered by a specific medical-travel programme.

Partially. The only publicly funded facility at Dr. F.H. Wigmore Regional Hospital in Moose Jaw closed in July 2021 due to COVID-related staffing shortages and has only partially reopened with reduced outpatient hours. Many patients are routed interprovincially.

When in-province capacity is unavailable, patients are most commonly referred to Foothills Medical Centre in Calgary, Alberta (approximately 675 km from Moose Jaw). Misericordia Community Hospital in Edmonton is an alternative for northern Saskatchewan patients.

Yes, for medically necessary treatment of recognised conditions when delivered at a publicly funded chamber. The Saskatchewan Health Authority arranges in-province treatment at Wigmore Hospital when chamber capacity allows, and may approve out-of-province referrals when capacity is not available.

No private hyperbaric clinics are operating in Saskatchewan as of April 2026. The province has only the publicly funded chamber at Dr. F.H. Wigmore Regional Hospital in Moose Jaw.

Saskatchewan references the 14 Health Canada-recognised conditions: carbon monoxide poisoning, decompression sickness, gas or air embolism, gas gangrene, necrotising soft-tissue infections, crush injury, severe anaemia, sudden sensorineural hearing loss, problem wounds, soft-tissue radiation necrosis, radiation damage affecting bone, compromised grafts and flaps, refractory osteomyelitis, and thermal burns. Intracranial abscess (UHMS Indication #8) and central retinal artery occlusion (a sub-presentation of arterial insufficiency) are additional UHMS-listed uses treated at some Canadian hospital hyperbaric programmes, not among the named Health Canada 14.

Most chronic indications require a course of 20 to 40 daily sessions, with some radiation indications requiring up to 60 sessions. Each session typically lasts 90 to 120 minutes. Acute emergencies may require only one or a few treatments.

Your physician initiates the referral to the receiving facility (commonly Foothills in Calgary or Misericordia in Edmonton) through the Saskatchewan Health Authority interprovincial referral process. Saskatchewan Ministry of Health may cover the medically necessary treatment cost; travel and accommodation are typically the patient's responsibility.

No firm reopening date has been published. The chamber has been operating on reduced outpatient hours since the partial reopening that followed the July 2021 closure. Patient advocates and opposition members of the legislature have called for full restoration of services. Confirm current status directly with Saskatchewan Health Authority before planning travel.

Hyperbaric oxygen therapy in Saskatchewan is available at Dr. F.H. Wigmore Regional Hospital in Moose Jaw, operating on reduced hours since the July 2021 COVID-related closure and partial reopening. There are no private HBOT clinics in Saskatchewan as of April 2026. When in-province capacity is unavailable, patients are referred interprovincially to Foothills Medical Centre in Calgary (approximately 675 km from Moose Jaw) or to Misericordia Community Hospital in Edmonton. To compare hyperbaric facilities anywhere in Canada, see <a href="/facilities/">our directory of all verified Canadian HBOT facilities</a>.

Hyperbaric oxygen therapy in Saskatchewan is accessed through Saskatchewan Health at Dr. F.H. Wigmore Regional Hospital, Moose Jaw (partially reopened, reduced hours) for the 14 Health Canada-recognised conditions with a physician referral. The referral pathway typically starts with a family physician or specialist (hyperbaric medicine, wound care, infectious disease, otolaryngology for sudden hearing loss, ophthalmology for retinal indications). The referring physician faxes the referral to the closest hospital hyperbaric unit, which schedules an in-person consultation; treatment begins after the unit's hyperbaric physician confirms clinical appropriateness. Emergency cases (carbon monoxide poisoning, decompression sickness, gas embolism) bypass the elective referral pathway and are accepted directly from emergency departments.

A standard HBOT session at hospital programmes and private clinics across Saskatchewan lasts 90 to 120 minutes door-to-door: roughly 10 to 15 minutes for compression to treatment depth, 60 to 90 minutes at treatment pressure (typically 2.0 to 2.8 ATA), and 10 to 15 minutes for decompression. Emergency indications such as carbon monoxide poisoning, decompression sickness, or air embolism may use shorter or longer protocols (typically 2 to 5 hours per session for severe cases). Most chronic-condition courses run 20 to 40 sessions delivered daily or near-daily over 4 to 8 weeks.

Private HBOT clinics in nearby provinces typically quote $150 to $400 per session for self-pay treatment, with a full 20 to 40 session course totalling approximately $3,000 to $16,000. Saskatchewan Health covers HBOT at Dr. F.H. Wigmore Regional Hospital, Moose Jaw (partially reopened, reduced hours) for the 14 Health Canada-recognised conditions with a physician referral, at no out-of-pocket cost. CPSA accreditation in Alberta or equivalent provincial standards elsewhere apply to private clinics; confirm billing arrangements with each clinic.

Hyperbaric oxygen therapy is generally safe when delivered in a Health Canada-licensed clinical-grade chamber under physician supervision. The most common side effects are temporary: middle-ear barotrauma during compression (managed by ear-clearing techniques), transient short-sightedness over long courses that reverses within weeks of finishing, and occasional sinus pressure. Rare serious risks include oxygen toxicity seizures (under 1 in 10,000 sessions at clinical pressures) and chamber-related pneumothorax expansion. Absolute contraindications are untreated pneumothorax, concurrent bleomycin chemotherapy, and concurrent disulfiram. Hospital programmes and CPSA-accredited private clinics follow detailed pre-treatment screening protocols.

Clinical-grade hyperbaric oxygen therapy delivers 100 per cent oxygen at 2.0 to 2.8 ATA inside a Health Canada-licensed chamber. "Mild" or "soft" hyperbaric chambers operate at 1.3 ATA or less, sometimes with ambient air rather than concentrated oxygen, and are not Health Canada-licensed for the 14 recognised indications. The clinical evidence base supporting HBOT specifically references pressures of 2.0 ATA and above; lower-pressure protocols do not produce the same dissolved-oxygen physiology. Saskatchewan Health and other provincial health plans cover treatment only at hospital programmes operating clinical-grade chambers.